Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-20-000398

Options or other derivatives

  • Director acquired 31,279 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
TREU JESSE I Director 2020-06-09 Grant or award · Stock Option (right to buy) +26,503 26,503 D: show line 1 in the form
TREU JESSE I Director 2020-06-09 Grant or award · Stock Option (right to buy) +2,465 2,465 D: show line 2 in the form
TREU JESSE I Director 2020-06-09 Grant or award · Stock Option (right to buy) +2,311 2,311 D: show line 3 in the form
Loading xslF345X03/edgar.xml…